WO2008015530A3 - Formulation orale solide stable d'un medicament acide labile - Google Patents

Formulation orale solide stable d'un medicament acide labile Download PDF

Info

Publication number
WO2008015530A3
WO2008015530A3 PCT/IB2007/002176 IB2007002176W WO2008015530A3 WO 2008015530 A3 WO2008015530 A3 WO 2008015530A3 IB 2007002176 W IB2007002176 W IB 2007002176W WO 2008015530 A3 WO2008015530 A3 WO 2008015530A3
Authority
WO
WIPO (PCT)
Prior art keywords
pantoprazole
solid oral
oral formulation
stable solid
relates
Prior art date
Application number
PCT/IB2007/002176
Other languages
English (en)
Other versions
WO2008015530A2 (fr
Inventor
Haranatha Babu Balanagu
Shailesh Suresh Bhamare
Kishor Dattatray Deo
Sumanth Reddy Vatti
Sivakumaran Meenakshisunderam
Original Assignee
Aurobindo Pharma Ltd
Haranatha Babu Balanagu
Shailesh Suresh Bhamare
Kishor Dattatray Deo
Sumanth Reddy Vatti
Sivakumaran Meenakshisunderam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd, Haranatha Babu Balanagu, Shailesh Suresh Bhamare, Kishor Dattatray Deo, Sumanth Reddy Vatti, Sivakumaran Meenakshisunderam filed Critical Aurobindo Pharma Ltd
Publication of WO2008015530A2 publication Critical patent/WO2008015530A2/fr
Publication of WO2008015530A3 publication Critical patent/WO2008015530A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une formulation stable comportant un composé à base de benzimidazole acide-labile. Plus particulièrement, la présente invention concerne une formulation stable comportant du pantoprazole ou ses sels pharmaceutiquement acceptables. La présente invention concerne également un procédé de préparation d'une formulation stable contenant du pantoprazole ou ses sels pharmaceutiquement acceptables.
PCT/IB2007/002176 2006-08-03 2007-07-30 Formulation orale solide stable d'un medicament acide labile WO2008015530A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1380CH2006 2006-08-03
IN1380/CHE/2006 2006-08-03

Publications (2)

Publication Number Publication Date
WO2008015530A2 WO2008015530A2 (fr) 2008-02-07
WO2008015530A3 true WO2008015530A3 (fr) 2009-02-26

Family

ID=38720303

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002176 WO2008015530A2 (fr) 2006-08-03 2007-07-30 Formulation orale solide stable d'un medicament acide labile

Country Status (1)

Country Link
WO (1) WO2008015530A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102406656A (zh) * 2011-11-21 2012-04-11 南开大学 碳酸氢钠肠溶片及制备方法
CN105380919A (zh) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 一种泮托拉唑钠肠溶片及其制备方法
GB201804621D0 (en) * 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002020A1 (fr) * 1995-07-05 1997-01-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Composition pharmaceutique administrable par voie orale contenant des agents actifs antimicrobiens et du pantoprazole a liberation differee
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
CA2557791A1 (fr) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. Preparation de lessivage maitrise et procede de fabrication de ladite preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002020A1 (fr) * 1995-07-05 1997-01-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Composition pharmaceutique administrable par voie orale contenant des agents actifs antimicrobiens et du pantoprazole a liberation differee
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
CA2557791A1 (fr) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. Preparation de lessivage maitrise et procede de fabrication de ladite preparation

Also Published As

Publication number Publication date
WO2008015530A2 (fr) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2007087548A3 (fr) Composés chimiques
WO2009051119A1 (fr) Composé de pyrimidylindoline
WO2006011159A3 (fr) Composition pharmaceutique stabilisee contenant du sodium de rabeprazole presentant une biodisponibilite amelioree
WO2007135527A3 (fr) Composés de benzimidazolyle
WO2009115178A3 (fr) Plaquette gingivale
WO2008096001A8 (fr) Phénylcarbamates macrocycliques inhibant le virus de l'hépatite c (vhc)
MX2010010647A (es) Proceso para preparar formulaciones de dabigatran para administracion oral.
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
WO2011012816A3 (fr) Formulation pharmaceutique
WO2009147170A3 (fr) Combinaisons de médicaments comprenant un inhibiteur de dgat et un agoniste de ppar
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2008136392A1 (fr) Préparation pour une administration orale
WO2008006795A3 (fr) Composés d'indole
WO2007017728A3 (fr) Nouveaux composes heterocycliques
WO2009105969A8 (fr) Analogues d'épothilone, leurs compositions pharmaceutiques, leur utilisation et leurs préparations
WO2009013545A3 (fr) Composés chimiques
WO2010049449A3 (fr) Nouveaux sels de sunitinib
NO20080033L (no) Kinolinderivater som NK3-antagonister
WO2009126861A3 (fr) Composés de triazolopyridine utiles en tant qu'inhibiteurs de dgat1
WO2007112913A3 (fr) Derives de benzimidazole
IN2012DN04868A (fr)
WO2009060952A1 (fr) Nouvelle préparation
WO2008081268A3 (fr) Compositions pharmaceutiques d'entacapone
WO2007007182A3 (fr) Formes galeniques solides d'agent antiepileptique
WO2008015530A3 (fr) Formulation orale solide stable d'un medicament acide labile

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07804668

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804668

Country of ref document: EP

Kind code of ref document: A2